Vir Biotechnology draws attention as healthcare strength, biotech sentiment, and pharmaceutical activity place clinical-stage ...

Sofinnova Investments’ Jim Healy says biotech innovation is thriving but is skeptical about artificial intelligence’s ability ...

Michael Schultz is director of venture operations at Portal Innovations, where he is always looking for innovations that could revolutionize the life sciences. "We work with many startups, and all of ...

Tsingke Biotech recently hosted the Oligonucleotide Drug Salon at the Hilton Shanghai Zhangjiang, bringing together experts from academia, biopharmaceutical companies, investment firms, and industry ...

SAN FRANCISCO--(BUSINESS WIRE)--As Demy-Colton and EBD Group’s Biotech Showcase™ concluded its 18 th year, the event continued to distinguish itself as a leading hub for early-stage biotechnology ...

The inventor of the groundbreaking Crispr gene-editing technology is skeptical about artificial intelligence replacing human ...

Medicare’s new GLP-1 Bridge program boosts seniors’ access to weight-loss drugs through 2027—see top GLP-1 and biotech stocks to watch now.

SYDNEY--(BUSINESS WIRE)--Novotech, a globally recognized full-service clinical research organization (CRO) and scientific advisory company, is featured in The Next Frontier, a global branded series ...

The United States's dominance in biotech innovation is crucial to our national interests and global security. In recent years, China has quickly become a powerhouse, bolstered by its biotech-friendly ...

In interviews as well as a panel at BIO’s annual meeting, investors and life sciences bankers predicted an acceleration in ...

In 2023, Chinese President Xi Jinping proclaimed: “Biopharmaceuticals is a strategic emerging industry vital to China’s economic growth, public welfare, and national security.” For seasoned China ...

Out of potentially billions of compounds screened during drug discovery, only a select few make it to the finish line. In oncology and autoimmune, where patient response to immunotherapy is highly ...